Syngene Intl.

SYNGENE26 Apr 2024

Pharmaceuticals

₹

-0.70 (-0.10%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Syngene Intl.

Syngene Intl.

Pharmaceuticals

SYNGENE26 Apr 2024

₹

-0.70 (-0.10%)

OverviewFundamentalsFutures Options

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
24-Apr-2024	D	The Board of Directors recommends Final Dividend of Rs. 1.25/- per share.	28-Jun-2024
26-Apr-2023	D	Board approved:- 1. The Board recommended a final dividend of Re. 1.25/- per Equity Share of Rs. 10/-(comprising a regular dividend of Re. 0.50 per share and a special additional dividend of Re. 0.75 per share to mark the 30th anniversary of the founding of the Company in November 1993) subject to shareholders' approval at the ensuing Annual General Meeting of the Company. The record date is fixed as Friday, June 30, 2023 for payment of dividend. The dividend will be paid within 30 days from the date of shareholders' approval. Annual General Meeting: 2. Cconvening of the 30th Annual General Meeting of the Company on Wednesday, July 26, 2023	30-Jun-2023
26-Apr-2023	D	Board approved:- 1. The Board recommended a final dividend of Re. 1.25/- per Equity Share of Rs. 10/-(comprising a regular dividend of Re. 0.50 per share and a special additional dividend of Re. 0.75 per share to mark the 30th anniversary of the founding of the Company in November 1993) subject to shareholders' approval at the ensuing Annual General Meeting of the Company. The record date is fixed as Friday, June 30, 2023 for payment of dividend. The dividend will be paid within 30 days from the date of shareholders' approval. Annual General Meeting: 2. Cconvening of the 30th Annual General Meeting of the Company on Wednesday, July 26, 2023	30-Jun-2023
27-Apr-2022	D	Syngene International Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 27, 2022, inter alia, has considered and approved the following: Recommended final dividend of Re. 1/- per Equity Share of Rs. 10/- each of the Company (comprising a regular dividend of Re. 0.50 per share and a special additional dividend of Re. 0.50 per share) for the Financial year March 31, 2022 subject to shareholders' approval at the ensuing Annual General Meeting of the Company. The dividend will be paid within 30 days from the date of shareholders' approval at the ensuing Annual General Meeting.	30-Jun-2022
27-Apr-2022	D	Syngene International Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 27, 2022, inter alia, has considered and approved the following: Recommended final dividend of Re. 1/- per Equity Share of Rs. 10/- each of the Company (comprising a regular dividend of Re. 0.50 per share and a special additional dividend of Re. 0.50 per share) for the Financial year March 31, 2022 subject to shareholders' approval at the ensuing Annual General Meeting of the Company. The dividend will be paid within 30 days from the date of shareholders' approval at the ensuing Annual General Meeting.	30-Jun-2022
25-Apr-2019	D	Syngene International Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 24, 2019, inter alia, has considered and approved the following: 1. Recommended final dividend at a rate of 5% i.e. Rs. 0.50 per equity share for the financial year ended March 31, 2019, subject to shareholders' approval at the ensuing Annual General Meeting and the dividend will be paid within 30 days from the date of shareholder's approval at the ensuing Annual General Meeting. Please find attached the Outcome of the Board Meeting held April 24, 2019. (As Per BSE Announcement Dated 24.04.2019)	16-Jul-2019
25-Apr-2018	D	Syngene International Ltd has informed BSE that the Board of Directors at its meeting held on April 25, 2018, inter alia, has considered and approved the following: - Recommended a final dividend at a rate of 10% i.e. Rs. 1.00 per equity share for the financial year ended March 31, 2018, subject to shareholders' approval at the ensuing Annual General Meeting.	17-Jul-2018
27-Apr-2017	D	Financials Results for the quarter and year ended March 31, 2017	20-Jul-2017
11-Mar-2016	D	Syngene International Ltd has informed BSE that the Board of Directors of the Company vide its circular resolution dated March 11, 2016 has approved the payment of Interim dividend at a rate of 10% i.e. (Re. 1/- per share) for the financial year 2015-16. The said Interim dividend, will be paid on March 29, 2016.	17-Mar-2016
30-May-2019	B	1:1 Bonus Issue of Equity Shares Trading Members of the Exchange are hereby informed that, Syngene International Limited has fixed the record date for the purpose of Bonus Issue. The transactions in the equity shares of the company would be on an ex-bonus basis with effect from the under mentioned date. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Syngene International Limited (539268) RECORD DATE 12.06.2019 PURPOSE Issue of 1 (One) Bonus equity share of Rs.10/- each for every 1 (One) existing equity share of Rs.10/- each held. Ex-Bonus basis from Date & Sett. No. 11/06/2019 DR-049/2019-2020 Trading Members of the Exchange are requested to take of it. (As Per BSE Notice Dated on 07.06.2019)	12-Jun-2019	1:1
24-Apr-2024	BC	Convening of the 31st Annual General Meeting of the Company on Wednesday, July 24, 2024. Copy of the notice convening the Annual General Meeting will be sent in due course	24-Jul-2024
24-Apr-2024	BC	The Board of Directors recommends Final Dividend of Rs. 1.25/- per share.	28-Jun-2024
24-Apr-2024	BC	12.5% Final Dividend	28-Jun-2024
01-Apr-2024	BC	Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/04/2024 inter alia to consider and approve the audited standalone and consolidat	24-Apr-2024
24-Apr-2024	BC	Outcome of the Board Meeting - April 24, 2024	24-Apr-2024

Announcement Date24-Apr-2024

Ex Dividend Date28-Jun-2024

Dividend(%)12

Announcement Date26-Apr-2023

Ex Dividend Date30-Jun-2023

Dividend(%)5

Announcement Date26-Apr-2023

Ex Dividend Date30-Jun-2023

Dividend(%)8

Announcement Date27-Apr-2022

Ex Dividend Date30-Jun-2022

Dividend(%)5

Announcement Date27-Apr-2022

Ex Dividend Date30-Jun-2022

Dividend(%)5

Announcement Date25-Apr-2019

Ex Dividend Date16-Jul-2019

Dividend(%)5

Announcement Date25-Apr-2018

Ex Dividend Date17-Jul-2018

Dividend(%)10

Announcement Date27-Apr-2017

Ex Dividend Date20-Jul-2017

Dividend(%)10

Announcement Date11-Mar-2016

Ex Dividend Date17-Mar-2016

Dividend(%)10

No Rights has been declared by SYNGENE

Book Closure

Record Date	Split Date	Purpose
24-Jul-2024	-	Convening of the 31st Annual General Meeting of the Company on Wednesday, July 24, 2024. Copy of the notice convening the Annual General Meeting will be sent in due course
28-Jun-2024	-	The Board of Directors recommends Final Dividend of Rs. 1.25/- per share.
28-Jun-2024	-	12.5% Final Dividend
24-Apr-2024	-	Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/04/2024 inter alia to consider and approve the audited standalone and consolidat
24-Apr-2024	-	Outcome of the Board Meeting - April 24, 2024

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Syngene International Ltd ₹698.25(-0.70/-0.10%)	698.25	-0.70	28,107.14	12.00	59.07	6.70
Astrazeneca Pharma India Ltd ₹5,415.40(+81.55/1.53%)	5,415.40	+81.55	13,538.50	71.09	84.88	20.67
Bliss GVS Pharma Ltd ₹122.60(+5.85/5.01%)	122.60	+5.85	1,283.51	60.79	18.80	1.31
Cipla Ltd ₹1,409.40(+4.00/0.28%)	1,409.40	+4.00	113,794.25	54.54	34.60	4.40
Abbott India Ltd ₹25,864.85(+201.35/0.78%)	25,864.85	+201.35	54,962.81	15.87	47.98	17.68
Amrutanjan Health Care Ltd ₹680.85(-8.80/-1.28%)	680.85	-8.80	1,968.38	13.21	44.73	7.51

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Gross Sales	864.70	791.90	830.70	715.80	994.40	786.60
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	864.70	791.90	830.70	715.80	994.40	786.60
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	15.30	28.80	21.00	22.90	22.80	17.20
Total Income	880.00	820.70	851.70	738.70	1017.20	803.80
Total Expenditure	565.40	596.10	621.50	552.40	678.00	556.20
PBIDT	314.60	224.60	230.20	186.30	339.20	247.60
Interest	8.50	6.30	8.60	6.10	10.40	13.70
PBDT	306.10	218.30	221.60	180.20	328.80	233.90
Depreciation	95.70	93.60	90.90	88.70	88.10	94.60
Tax	41.50	19.10	22.80	16.40	42.10	26.00
Deferred Tax	-20.90	5.80	6.30	-0.20	9.60	3.80
Reported Profit After Tax	189.80	99.80	101.60	75.30	189.00	109.50
Extra-ordinary Items	0.00	-2.96	-5.75	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	189.80	102.76	107.35	75.30	189.00	109.50

EPS (Unit Curr.)	4.73	2.49	2.53	1.88	4.71	2.73
EPS (Adj) (Unit Curr.)	4.73	2.49	2.53	1.88	4.71	2.73
Calculated EPS (Unit Curr.)	4.72	2.48	2.53	1.87	4.71	2.73
Calculated EPS (Adj) (Unit Curr.)	4.72	2.48	2.53	1.87	4.71	2.73
Calculated EPS (Ann.) (Unit Curr.)	18.89	9.93	10.11	7.49	18.83	10.91
Calculated EPS (Adj) (Ann.) (Unit Curr.)	18.89	9.93	10.11	7.49	18.83	10.91
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	402.00	402.00	402.00	402.00	401.40	401.40
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	36.38	28.36	27.71	26.03	34.11	31.48
PBDTM(%)	35.40	27.57	26.68	25.17	33.07	29.74
PATM(%)	21.95	12.60	12.23	10.52	19.01	13.92

Column	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Gross Sales	916.90	853.50	910.10	808.10	994.40	785.90
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	916.90	853.50	910.10	808.10	994.40	785.90
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	16.10	29.30	21.60	23.60	22.80	17.20
Total Income	933.00	882.80	931.70	831.70	1017.20	803.10
Total Expenditure	600.00	625.70	663.40	596.20	680.30	554.90
PBIDT	333.00	257.10	268.30	235.50	336.90	248.20
Interest	12.90	10.80	13.00	10.50	10.40	13.70
PBDT	320.10	246.30	255.30	225.00	326.50	234.50
Depreciation	111.10	108.10	104.60	102.10	95.60	94.60
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	42.40	24.50	29.80	26.30	42.60	26.40
Deferred Tax	-22.00	2.20	4.40	3.20	9.60	3.80
Reported Profit After Tax	188.60	111.50	116.50	93.40	178.70	109.70
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	188.60	111.50	116.50	93.40	178.70	109.70

Extra-ordinary Items	0.00	-2.99	-5.72	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	188.60	114.49	122.22	93.40	178.70	109.70

EPS (Unit Curr.)	4.70	2.78	2.90	2.33	4.36	2.74
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	402.00	402.00	402.00	402.00	401.40	401.40

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	36.32	30.12	29.48	29.14	33.88	31.58
PBDTM(%)	34.91	28.86	28.05	27.84	32.83	29.84
PATM(%)	20.57	13.06	12.80	11.56	17.97	13.96

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	401.40	400.80	400.00	400.00	200.00	200.00
Reserves Total	3217.50	2891.20	2418.30	1774.10	1767.20	1520.10
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	3618.90	3292.00	2818.30	2174.10	1967.20	1720.10
Secured Loans	575.30	531.50	512.40	376.70	606.60	692.60
Unsecured Loans	63.30	490.10	380.50	396.20	206.70	94.80
Total Debt	638.60	1021.60	892.90	772.90	813.30	787.40
Total Liabilities	4257.50	4313.60	3711.20	2947.00	2780.50	2507.50
APPLICATION OF FUNDS :
Gross Block	4071.20	3943.50	3460.00	3017.20	2171.00	1660.70
Less : Accumulated Depreciation	1811.20	1550.70	1259.00	997.50	794.20	630.30
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	2260.00	2392.80	2201.00	2019.70	1376.80	1030.40
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	126.20	346.40	237.20	234.10	273.70	155.40
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	940.80	1034.40	702.30	776.70	716.30	158.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	332.80	179.40	59.60	25.20	43.40	86.00
Sundry Debtors	484.40	508.20	474.40	398.20	338.70	266.80
Cash and Bank	509.30	515.10	638.20	280.30	435.40	966.50
Loans and Advances	733.40	237.10	205.50	169.30	229.10	242.30
Total Current Assets	2059.90	1439.80	1377.70	873.00	1046.60	1561.60
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	1210.10	869.40	795.30	795.10	640.20	555.20
Provisions	60.80	82.20	59.80	53.20	36.80	26.20
Total Current Liabilities	1270.90	951.60	855.10	848.30	677.00	581.40
Net Current Assets	789.00	488.20	522.60	24.70	369.60	980.20
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	201.60	190.30	188.50	208.30	124.60	118.40
Deferred Tax Liability	122.10	125.20	99.80	85.60	33.10	46.00
Net Deferred Tax	79.50	65.10	88.70	122.70	91.50	72.40
Total Assets	4195.50	4326.90	3751.80	3177.90	2827.90	2396.40
Contingent Liabilities	621.90	547.80	859.60	849.20	671.60	238.50

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	401.40	400.80	400.00	400.00	200.00	200.00
Reserves Total	3216.60	2896.80	2421.40	1775.80	1768.40	1520.40
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	3618.00	3297.60	2821.40	2175.80	1968.40	1720.40
Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00
Secured Loans	575.30	531.50	512.40	376.70	606.60	692.60
Unsecured Loans	239.90	490.10	380.50	396.20	206.70	94.80
Total Debt	815.20	1021.60	892.90	772.90	813.30	787.40
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	321.60	295.60	311.20	366.70	244.80	99.50
Total Liabilities	4754.80	4614.80	4025.50	3315.40	3026.50	2607.30
APPLICATION OF FUNDS :
Gross Block	4558.90	3943.50	3460.00	3017.20	2171.00	1660.70
Less: Accumulated Depreciation	1892.00	1550.70	1259.00	997.50	794.20	630.30
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	2666.90	2392.80	2201.00	2019.70	1376.80	1030.40
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	176.90	346.40	237.20	234.10	273.70	155.40
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	918.50	1034.10	702.00	776.40	716.00	157.70
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	332.80	179.40	59.60	25.20	43.40	86.00
Sundry Debtors	529.30	507.70	475.70	398.20	338.70	266.80
Cash and Bank	531.70	517.90	642.60	281.50	436.90	967.40
Loans and Advances	207.10	237.10	205.50	169.30	229.10	242.30
Total Current Assets	1600.90	1442.10	1383.40	874.20	1048.10	1562.50
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	1010.50	866.80	797.80	794.30	640.20	555.40
Provisions	65.70	82.20	59.90	53.20	36.80	26.30
Total Current Liabilities	1076.20	949.00	857.70	847.50	677.00	581.70
Net Current Assets	524.70	493.10	525.70	26.70	371.10	980.80
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	194.10	190.70	188.90	208.30	124.60	118.40
Deferred Tax Liability	124.50	125.10	99.80	85.60	33.10	46.00
Net Deferred Tax	69.60	65.60	89.10	122.70	91.50	72.40
Other Assets	398.20	282.80	270.50	135.80	197.40	210.60
Total Assets
Contingent Liabilities	621.90	1095.60	859.60	424.70	335.90	476.80

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	259.00	318.90	191.80	163.70	251.80
Net Cash from Operating Activities	838.40	582.20	698.00	677.40	629.80
Net Cash Used In Investing Activities	-685.10	-610.80	-628.90	-423.80	-645.50
Net Cash Used In Financing Activities	-340.20	-31.30	58.00	-225.50	-72.40
Net Inc./Dec In Cash And Cash Equivalents	-186.90	-59.90	127.10	28.10	-88.10
Cash And Cash Equivalents At End Of The Year	72.10	259.00	318.90	191.80	163.70

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

54.79%

FII Shareholding

20.92%

DII Shareholding

15.80%

Public Shareholding

8.17%

**Promoter pledged shareholding 54.79%

About Syngene International Ltd

Syngene International Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 28107.14 crores. It has reported a sales of Rs. 864.7 crores and a net profit of Rs. 189.8 crores for the quarter ended December 2018. The company management includes Kiran Mazumdar Shaw, Kiran Mazumdar Shaw,Catherine Patricia Rosenberg,Paul Frederick Blackburn,Vijay Kuchroo,Jonathan Hunt,Vinita Bali,Priyadarshnini Mahapatra,Sharmila Karve,Carl Decicco,Kush Parmar (Syngene International Ltd) among others.

Chairman

Kiran Mazumdar Shaw

Registered office

Biocon SEZ Biocon Park,Plot No 2 & 3 Bommasandra Inds,Bengaluru,Karnataka,560099

FAX :91-80-28083189

Background

Incorporation Year1993

Face Value₹10

Market Lot1

How to buy Syngene Intl. shares on nse?

To buy Syngene Intl. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Syngene Intl. share price today?

The Syngene Intl. shares price on nse is Rs.698.25 today.

What is the market cap of Syngene Intl. shares on BSE ?

The company has a market capitalization of Rs.28107.14Cr

What is the PE & PB ratio of Syngene Intl. shares ?

PE is 59.07 and PB is 6.7

What is the 52 Week High and Low of Syngene Intl. shares?

Syngene Intl. stock price high: Rs.860.2 Syngene Intl. stock price low: Rs.632